Published in Carbohydr Res on September 02, 1992
Cryptococcosis in the era of AIDS--100 years after the discovery of Cryptococcus neoformans. Clin Microbiol Rev (1995) 8.81
Complementation of a capsule-deficient mutation of Cryptococcus neoformans restores its virulence. Mol Cell Biol (1994) 4.22
Polysaccharide antigens of the capsule of Cryptococcus neoformans. Infect Immun (1994) 3.46
The second capsule gene of cryptococcus neoformans, CAP64, is essential for virulence. Infect Immun (1996) 2.67
Cryptococcus neoformans chemotyping by quantitative analysis of 1H nuclear magnetic resonance spectra of glucuronoxylomannans with a computer-simulated artificial neural network. Clin Diagn Lab Immunol (1998) 2.10
Isolation of the third capsule-associated gene, CAP60, required for virulence in Cryptococcus neoformans. Infect Immun (1998) 2.10
The capsule of the fungal pathogen Cryptococcus neoformans. Adv Appl Microbiol (2009) 1.97
Variation in the structure of glucuronoxylomannan in isolates from patients with recurrent cryptococcal meningitis. Infect Immun (1995) 1.70
Cryptococcus neoformans and cryptococcal glucuronoxylomannan, galactoxylomannan, and mannoprotein induce different levels of tumor necrosis factor alpha in human peripheral blood mononuclear cells. Infect Immun (1997) 1.28
Reactivity patterns and epitope specificities of anti-Cryptococcus neoformans monoclonal antibodies by enzyme-linked immunosorbent assay and dot enzyme assay. Infect Immun (1997) 1.27
Radial mass density, charge, and epitope distribution in the Cryptococcus neoformans capsule. Eukaryot Cell (2006) 1.21
Serotyping of Cryptococcus neoformans by dot enzyme assay. J Clin Microbiol (1996) 1.04
Determination of antigen binding specificities of Cryptococcus neoformans factor sera by enzyme-linked immunosorbent assay. Infect Immun (1995) 0.99
Aggregation of Cryptococcus neoformans by surfactant protein D is inhibited by its capsular component glucuronoxylomannan. Infect Immun (2004) 0.85
Improved diagnostic medium for separation of Cryptococcus neoformans var. neoformans (serotypes A and D) and Cryptococcus neoformans var. gattii (serotypes B and C). J Clin Microbiol (1982) 6.78
Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med (2001) 6.27
A new genus, filobasidiella, the perfect state of Cryptococcus neoformans. Mycologia (1976) 6.24
A rare genotype of Cryptococcus gattii caused the cryptococcosis outbreak on Vancouver Island (British Columbia, Canada). Proc Natl Acad Sci U S A (2004) 6.21
Epidemiologic differences between the two varieties of Cryptococcus neoformans. Am J Epidemiol (1984) 5.74
Melanin-lacking mutants of Cryptococcus neoformans and their virulence for mice. J Bacteriol (1982) 5.40
Encapsulation and melanin formation as indicators of virulence in Cryptococcus neoformans. Infect Immun (1986) 4.91
Taxonomic studies on Filobasidiella species and their anamorphs. Antonie Van Leeuwenhoek (1982) 4.90
Morphogenesis of Filobasidiella neoformans, the sexual state of Cryptococcus neoformans. Mycologia (1977) 4.83
Complementation of a capsule-deficient mutation of Cryptococcus neoformans restores its virulence. Mol Cell Biol (1994) 4.22
Epidemiologic differences among serotypes of Cryptococcus neoformans. Am J Epidemiol (1977) 3.91
Isolation of the URA5 gene from Cryptococcus neoformans var. neoformans and its use as a selective marker for transformation. Mol Cell Biol (1990) 3.91
Effect of the laccase gene CNLAC1, on virulence of Cryptococcus neoformans. J Exp Med (1996) 3.76
Distribution of alpha and alpha mating types of Cryptococcus neoformans among natural and clinical isolates. Am J Epidemiol (1978) 3.55
A new species of Filobasidiella, the sexual state of Cryptococcus neoformans B and C serotypes. Mycologia (1977) 3.28
Phenoloxidase activity and virulence in isogenic strains of Cryptococcus neoformans. Infect Immun (1982) 3.13
Structure and antigenic activity of the capsular polysaccharide of Cryptococcus neoformans serotype A. Mol Immunol (1980) 2.98
Biochemical studies of phenoloxidase and utilization of catecholamines in Cryptococcus neoformans. J Bacteriol (1982) 2.98
Genetic evidence for role of extracellular proteinase in virulence of Candida albicans. Infect Immun (1985) 2.91
The developmentally regulated alb1 gene of Aspergillus fumigatus: its role in modulation of conidial morphology and virulence. J Bacteriol (1998) 2.78
Microtitration plate enzyme immunoassay to detect PCR-amplified DNA from Candida species in blood. J Clin Microbiol (1995) 2.75
The second capsule gene of cryptococcus neoformans, CAP64, is essential for virulence. Infect Immun (1996) 2.67
Rapid identification of Candida species with species-specific DNA probes. J Clin Microbiol (1998) 2.65
Creatinine metabolism in Cryptococcus neoformans and Cryptococcus bacillisporus. J Bacteriol (1980) 2.52
Chromosomal rearrangement in Candida stellatoidea results in a positive effect on phenotype. Infect Immun (1991) 2.52
A developmentally regulated gene cluster involved in conidial pigment biosynthesis in Aspergillus fumigatus. J Bacteriol (1999) 2.50
Genetic differences between type I and type II Candida stellatoidea. Infect Immun (1989) 2.38
Molecular and genetic analysis of URA5 transformants of Cryptococcus neoformans. Infect Immun (1992) 2.32
Deletion of the Candida glabrata ERG3 and ERG11 genes: effect on cell viability, cell growth, sterol composition, and antifungal susceptibility. Antimicrob Agents Chemother (1995) 2.32
Restriction fragment polymorphism in mitochondrial DNA of Cryptococcus neoformans. J Gen Microbiol (1989) 2.28
Nucleotide sequence analysis of the 5.8S rDNA and adjacent ITS2 region of Candida albicans and related species. Yeast (1993) 2.26
Current trends in immunodiagnosis of candidiasis and aspergillosis. Rev Infect Dis (1984) 2.22
Comparison of the electrophoretic karyotypes and chromosomal location of ten genes in the two varieties of Cryptococcus neoformans. Microbiology (1994) 2.14
Microevolution of a standard strain of Cryptococcus neoformans resulting in differences in virulence and other phenotypes. Infect Immun (1998) 2.12
DNA probe for strain typing of Cryptococcus neoformans. J Clin Microbiol (1992) 2.12
Serological, electrophoretic, and biological properties of Cryptococcus neoformans antigens. Infect Immun (1988) 2.11
Isolation of the third capsule-associated gene, CAP60, required for virulence in Cryptococcus neoformans. Infect Immun (1998) 2.10
Cell-wall glucans of Cryptococcus neoformans Cap 67. Carbohydr Res (1990) 2.08
Studies on Emmonsiella capsulata (Histoplasma capsulatum). II. Distribution of the two mating types in 13 endemic states of the United States. Am J Epidemiol (1974) 2.06
New, special stain for histopathological diagnosis of cryptococcosis. J Clin Microbiol (1981) 2.04
Aspergillus nidulans infection in chronic granulomatous disease. Medicine (Baltimore) (1998) 2.03
Galactomannan antigenemia in invasive aspergillosis. Infect Immun (1979) 1.94
IL-12 prevents mortality in mice infected with Histoplasma capsulatum through induction of IFN-gamma. J Immunol (1995) 1.94
Multiple immunoreactive molecular forms of parathyroid hormone in human serum. 1. Proc Soc Exp Biol Med (1972) 1.86
Successful treatment of Paecilomyces varioti infection in a patient with chronic granulomatous disease and a review of Paecilomyces species infections. Clin Infect Dis (1992) 1.84
Concentrations of airborne Aspergillus compared to the incidence of invasive aspergillosis: lack of correlation. Med Mycol (1998) 1.83
Biochemical differences between serotypes of Cryptococcus neoformans. Sabouraudia (1978) 1.83
Fractionation and characterization of galactoxylomannan from Cryptococcus neoformans. Carbohydr Res (1984) 1.79
Isolation, characterization, and localization of a capsule-associated gene, CAP10, of Cryptococcus neoformans. J Bacteriol (1999) 1.79
Physical and genetic mapping of Candida albicans: several genes previously assigned to chromosome 1 map to chromosome R, the rDNA-containing linkage group. Infect Immun (1991) 1.79
Rapid method to extract DNA from Cryptococcus neoformans. J Clin Microbiol (1991) 1.78
Detection of antibodies and antigenemia in leukemic patients with candidiasis by enzyme-linked immunosorbent assay. J Infect Dis (1981) 1.77
Candida albicans in patients with the acquired immunodeficiency syndrome: absence of a novel of hypervirulent strain. J Infect Dis (1990) 1.77
Serological and cellular immune activity of peptidoglucomannan fractions of Candida albicans cell walls. Infect Immun (1974) 1.76
Genome variation in Cryptococcus gattii, an emerging pathogen of immunocompetent hosts. MBio (2011) 1.76
Structural studies on the major, capsular polysaccharide from Cryptococcus bacillisporus serotype B. Carbohydr Res (1980) 1.74
Melanogenesis in Cryptococcus neoformans. J Gen Microbiol (1988) 1.73
Structural characterization of the galactoxylomannan of Cryptococcus neoformans Cap67. Carbohydr Res (1998) 1.72
Cryptococcus neoformans STE12alpha regulates virulence but is not essential for mating. J Exp Med (2000) 1.71
Physiologic hyperparathyroidism in pregnancy. J Clin Endocrinol Metab (1972) 1.70
High prevalence of Cryptococcus neoformans var. gattii in tropical and subtropical regions. Zentralbl Bakteriol Mikrobiol Hyg A (1984) 1.68
Nutritional physiology and taxonomy of human-pathogenic Cladosporium-Xylohypha species. J Med Vet Mycol (1996) 1.67
On the structure of the capsular polysaccharide from Cryptococcus neoformans serotype C. Immunochemistry (1978) 1.66
Caclium, phosphorus, and bone in renal disease and transplantation. Arch Intern Med (1969) 1.66
On the pathogenesis of hyperparathyroidism in chronic experimental renal insufficiency in the dog. J Clin Invest (1971) 1.66
Concomitant but not causal association between surface charge and inhibition of phagocytosis by cryptococcal polysaccharide. Infect Immun (1980) 1.65
Cryptococcus neoformans CAP59 (or Cap59p) is involved in the extracellular trafficking of capsular glucuronoxylomannan. Eukaryot Cell (2004) 1.64
Sequence analysis of the internal transcribed spacer 2 (ITS2) from yeast species within the genus Candida. Curr Microbiol (1998) 1.64
On the origins of congenic MATalpha and MATa strains of the pathogenic yeast Cryptococcus neoformans. Fungal Genet Biol (1999) 1.60
Phenotypic switching in Cryptococcus neoformans results in changes in cellular morphology and glucuronoxylomannan structure. Infect Immun (1999) 1.60
Cryptococcus neoformans induces alterations in the cytoskeleton of human brain microvascular endothelial cells. J Med Microbiol (2003) 1.59
Production and regeneration of protoplasts from Cryptococcus. Sabouraudia (1985) 1.59
Enzyme immunoassay detection of IgM to galactoxylomannan of Cryptococcus neoformans. Diagn Immunol (1984) 1.57
Comparative serological and cutaneous reactivity of candidal cytoplasmic proteins and mannan separated by affinity for concanavalin A. J Clin Microbiol (1977) 1.56
Characterization of Cryptococcus neoformans capsular glucuronoxylomannan polysaccharide with monoclonal antibodies. Infect Immun (1989) 1.55
Dissociation of mannan--serum complexes and detection of Candida albicans mannan by enzyme immunoassay variations. Clin Chem (1982) 1.54
Localization of mannoprotein in Cryptococcus neoformans. J Bacteriol (1989) 1.52
Biochemical characterization of Candida albicans epitopes that can elicit protective and nonprotective antibodies. Infect Immun (1997) 1.52
Diversity of DNA fingerprints in Cryptococcus neoformans. J Clin Microbiol (1995) 1.50
The role of phosphate in the secretion of parathyroid hormone in man. J Clin Invest (1970) 1.50
Capsular polysaccharides from a parent strain and from a possible, mutant strain of Cryptococcus neoformans serotype A. Carbohydr Res (1981) 1.48
Activation of renal cortical adenylate cyclase by circulating immunoreactive parathyroid hormone fragments. J Clin Invest (1973) 1.47
Application of radioimmunoassay to differentiation of adenoma and hyperplasia and to preoperative localization of hyperfunctioning parathyroid glands. N Engl J Med (1969) 1.44
Experience with a radioimmunoassay of parathyroid hormone in human sera. Trans Assoc Am Physicians (1968) 1.44
Induction of TNF-alpha in human peripheral blood mononuclear cells by the mannoprotein of Cryptococcus neoformans involves human mannose binding protein. J Immunol (1997) 1.43
Galactoxylomannans of Cryptococcus neoformans. Infect Immun (1992) 1.42
Comparison of serum mannan, arabinitol, and mannose in experimental disseminated candidiasis. J Clin Microbiol (1984) 1.41
Studies on Emmonsiella capsulata. I. Heterothallism and development of the ascocarp. Mycologia (1973) 1.41
The structure of the capsular polysaccharide from Cryptococcus neoformans serotype D. Carbohydr Res (1979) 1.41
Comparison of enzyme immunoassay and gas-liquid chromatography for the rapid diagnosis of invasive candidiasis in cancer patients. J Clin Microbiol (1985) 1.41
Structure determination of Cryptococcus neoformans serotype A-variant glucuronoxylomannan by 13C-n.m.r. spectroscopy. Carbohydr Res (1988) 1.41
Monoclonal antibodies against Candida tropicalis mannan: antigen detection by enzyme immunoassay and immunofluorescence. J Clin Microbiol (1986) 1.40
Evidence for secondary hyperparathyroidism in idiopathic hypercalciuria. J Clin Invest (1973) 1.39